Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Barry D, Rutherford"'
Autor:
David R. Holmes, John A. House, Steven P. Marso, Barry D. Rutherford, J. Aaron Grantham, John A. Spertus
Publikováno v:
JACC: Cardiovascular Interventions. 2(6):479-486
Coronary chronic total occlusions (CTOs) are commonly encountered complex lesions identified in 15% of all patients referred for coronary angiography. Chronic total occlusion remains the most powerful predictor of referral for coronary bypass surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e8960f6f64f2676a817a98acc9785d
Autor:
George Dangas, Barry D. Rutherford, Gregg W. Stone, Martin Fahy, Bruce R. Brodie, Alexandra J. Lansky, Roxana Mehran, Deepak L. Bhatt, David A. Cox, Cindy L. Grines, E. Magnus Ohman, Frederick Feit, Helen Parise
Publikováno v:
American Heart Journal. 156:44-56
Background Advances in coronary angioplasty and adjunct pharmacology have improved patient outcomes after primary percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI). However, several areas for improvement remain. Hemorrhagi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8151b2d3998cd1e63e4b65baf2d7b93
https://doi.org/10.1016/j.ahj.2008.02.008
https://doi.org/10.1016/j.ahj.2008.02.008
Publikováno v:
US Cardiology Review. 5:34-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d9322cd41f8f2e767d744293a2a8aba
https://doi.org/10.15420/usc.2008.5.1.34
https://doi.org/10.15420/usc.2008.5.1.34
Autor:
Heinz P. Schultheiss, Alexandra J. Lansky, Todd D. Miller, Mark Turco, Anna Kalynych, Gregg W. Stone, Mitchell W. Krucoff, Steven P. Marso, Mansoor Qureshi, Raymond J. Gibbons, Barry D. Rutherford, Roxana Mehran
Publikováno v:
The American Journal of Cardiology. 100:206-210
Diabetes mellitus is strongly associated with increased cardiovascular morbidity and mortality in patients with ST-segment elevation myocardial infarction. It is unknown whether myocardial perfusion is decreased in diabetic compared with nondiabetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ebe782425a50bd8da182c49f04c27a
https://doi.org/10.1016/j.amjcard.2007.02.080
https://doi.org/10.1016/j.amjcard.2007.02.080
Autor:
Roxana Mehran, Yingbo Na, Mark Turco, Alexandra J. Lansky, John G. Webb, David Antoniucci, Barry D. Rutherford, Gregg W. Stone, Anna Kalynych, Heinz P. Schultheiss, Tom Stuckey, Raymond J. Gibbons, Daniel Dulas, Mitch Krucoff, Bruce R. Brodie, Mansoor Qureshi, David A. Cox
Publikováno v:
The American Journal of Cardiology. 99:1680-1686
The impact of time to treatment on outcomes after primary percutaneous coronary intervention (PCI) is controversial, and there are few data about time to treatment and infarct size. The EMERALD trial randomly assigned 501 high-risk patients with ST-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95b9364ba361665766c285f026bae72
https://doi.org/10.1016/j.amjcard.2007.01.047
https://doi.org/10.1016/j.amjcard.2007.01.047
Autor:
Roxana Mehran, Cindy L. Grines, Kishore J. Harjai, David A. Cox, Mark Turco, James E. Tcheng, John J. Griffin, Yingbo Na, Alexandra J. Lansky, Thomas Stuckey, Eulogio García, Giulio Guagliumi, Barry D. Rutherford, Gregg W. Stone
Publikováno v:
The American Journal of Cardiology. 99:202-207
We evaluated the utility of a routine postprocedure course of unfractionated heparin after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in patients not receiving glycoprotein IIb/IIIa inhibitors. In the CADIL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290fc7f9cf9ee7a10f4852253b15dc7e
https://doi.org/10.1016/j.amjcard.2006.07.084
https://doi.org/10.1016/j.amjcard.2006.07.084
Publikováno v:
Diabetes and Vascular Disease Research. 3:45-51
The objectives of this study were to evaluate angiographic and clinical outcomes among patients with diabetes mellitus (DM) who underwent percutaneous coronary intervention (PCI) for a chronic total occlusion (CTO). We compared them with matched pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92bf7c09e29ff6373a30ed4368f7c13
https://doi.org/10.3132/dvdr.2006.006
https://doi.org/10.3132/dvdr.2006.006
Autor:
Cindy L. Grines, David A. Cox, Yingbo Na, James E. Tcheng, Eulogio García, Mark Turco, Thomas Stuckey, Giulio Guagliumi, Amir Halkin, John J. Griffin, Roxana Mehran, Barry D. Rutherford, Gregg W. Stone
Publikováno v:
The American Journal of Cardiology. 96:1649-1655
Baseline features, management, and outcomes of patients who had acute myocardial infarction (AMI) and were excluded from randomized trials of primary percutaneous coronary intervention (PCI) have not been well described. We examined the baseline feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c9b41fb6732fa146eef7391ca67027
https://doi.org/10.1016/j.amjcard.2005.07.088
https://doi.org/10.1016/j.amjcard.2005.07.088
Autor:
Charles W. Barth, Steven P. Marso, Warren L. Johnson, Barry D. Rutherford, Kenneth C. Huber, Steven B. Laster, Roberto A. Corpus, John A. House, William C. Daniels, Lee V. Giorgi, J. Aaron Grantham
Publikováno v:
American Heart Journal. 148:493-500
The optimal percutaneous interventional strategy for dealing with significant non-culprit lesions in patients with multivessel disease (MVD) with acute myocardial infarction (AMI) at presentation remains controversial.A total of 820 patients treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48c50d61db5d2450bc1fea2c6f09942
https://doi.org/10.1016/j.ahj.2004.03.051
https://doi.org/10.1016/j.ahj.2004.03.051
Autor:
Warren K. Laskey, Alexandra J. Lansky, Wiwun Tantibhedhyangkul, Barry D. Rutherford, Theodore A. Bass, Paul S. Teirstein, Richard E. Kuntz, Raoul Bonan, Charles Wilmer, Sigmund Silber, Mohan Suntharalingam, Jeffrey J. Popma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 57:536-542
The management of diabetic patients with restenosis after percutaneous coronary intervention remains a significant challenge. Diabetic patients remain at significant risk of restenosis despite stent implantation. This retrospective analysis was perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c50dc371be1cc7cfe6465283e8f8ee
https://doi.org/10.1016/s0360-3016(03)00537-6
https://doi.org/10.1016/s0360-3016(03)00537-6